We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00579332
First Posted: December 24, 2007
Last Update Posted: April 27, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
American Institute of Cancer Prevention
Information provided by (Responsible Party):
Jay Fowke, Vanderbilt University
December 18, 2007
December 24, 2007
April 27, 2016
January 2005
Not Provided
change in blood PSA levels [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00579332 on ClinicalTrials.gov Archive Site
monitor for health events [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence
Effects of Brassica or Indole-3-Carbinol on Prostatectomy Patients With PSA Recurrenc
Pilot and feasibility diet and phyto-agent intervention among healthy men at risk for prostate cancer progression.
Not Provided
Interventional
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Prevention
Biochemical Failure
Dietary Supplement: brassica intervention
diet and phyto-chemical intervention
  • Placebo Comparator: 1
    one a day placebo
    Intervention: Dietary Supplement: brassica intervention
  • Experimental: 2
    Brassica intake
    Intervention: Dietary Supplement: brassica intervention
  • Experimental: 3
    indole-3-carbinol supplement
    Intervention: Dietary Supplement: brassica intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
December 2006
Not Provided

Inclusion Criteria:

  • Men with PSA recurrence following prostatectomy

Exclusion Criteria:

  • Not using exogenous hormones
Sexes Eligible for Study: Male
40 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00579332
041001
Yes
Not Provided
Not Provided
Jay Fowke, Vanderbilt University
Vanderbilt University
American Institute of Cancer Prevention
Principal Investigator: Jay H Fowke, PhD Vanderbilt University
Vanderbilt University
April 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP